TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
2.850
+0.050 (1.79%)
Dec 20, 2024, 4:00 PM EST - Market closed
TELA Bio Market Cap
TELA Bio has a market cap or net worth of $112.26 million as of December 20, 2024. Its market cap has decreased by -15.58% in one year.
Market Cap
112.26M
Enterprise Value
137.95M
1-Year Change
-15.58%
Ranking
Category
Stock Price
$2.85
Market Cap Chart
Since November 8, 2019, TELA Bio's market cap has decreased from $146.94M to $112.26M, a decrease of -23.60%. That is a compound annual growth rate of -5.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 112.26M | -30.76% |
| Dec 29, 2023 | 162.12M | -26.42% |
| Dec 30, 2022 | 220.33M | 18.68% |
| Dec 31, 2021 | 185.65M | -14.47% |
| Dec 31, 2020 | 217.06M | 46.96% |
| Dec 31, 2019 | 147.70M | 0.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PepGen | 118.32M |
| Sensus Healthcare | 116.37M |
| Cabaletta Bio | 116.33M |
| Tonix Pharmaceuticals Holding | 114.30M |
| Cassava Sciences | 113.06M |
| Leap Therapeutics | 111.51M |
| Protara Therapeutics | 111.19M |
| Acumen Pharmaceuticals | 111.15M |